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Abstract
Hair cells are the mechanotransducing cells of the inner ear that are essential for hearing and balance. POU4F3 – a POU-
domain transcription factor selectively expressed by these cells – has been shown to be essential for hair cell differentiation
and survival in mice and its mutation in humans underlies late-onset progressive hearing loss (DFNA15). The downstream
targets of POU4F3 are required for hair cell differentiation and survival. We aimed to identify such targets in order to
elucidate the molecular pathways involved in hair cell production and maintenance. The orphan thyroid nuclear receptor
Nr2f2 was identified as a POU4F3 target using a subtractive hybridization strategy and EMSA analysis showed that POU4F3
binds to two sites in the Nr2f2 59 flanking region. These sites were shown to be required for POU4F3 activation as their
mutation leads to a reduction in the response of an Nr2f2 59 flanking region reporter construct to POU4F3.
Immunocytochemistry was carried out in the developing and adult inner ear in order to investigate the relevance of this
interaction in hearing. NR2F2 expression in the postnatal mouse organ of Corti was shown to be detectable in all sensory
epithelia examined and characterised. These data demonstrate that Nr2f2 is a direct target of POU4F3 in vitro and that this
regulatory relationship may be relevant to hair cell development and survival.
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Introduction
POU4F3 is a member of the POU family of transcription
factors that regulate a wide array of neuroendocrine developmen-
tal pathways [1]. This family is characterised by the presence of a
bipartite DNA binding domain known as the POU domain which
comprises a POU-homeodomain and a POU-specific domain
separated by a linker [2]. All of these components are required for
sequence-specific DNA binding [3,4].
Though known to be expressed in the retina, spinal cord, dorsal
root ganglia and Merkel cells, the investigation of POU4F3
expression and function has focused on its role in the development
and maintenance of hair cells – the sensory cells of the inner ear
[5–8]. Homozygous Pou4f3 mutant mice demonstrate deafness
and balance deficits due to the failure of nascent hair cells – cells
that express hair cell markers – to develop into morphologically
recognisable hair cells and subsequent death of these cells [6–9].
Furthermore, heterozygous mutation of human POU4F3 is the
cause of autosomal dominant late-onset progressive hearing loss
(DFNA15) in several families [10–13].
As the molecular pathways involved in differentiation and
maintenance of hair cells are largely unknown, identification of the
downstream targets of POU4F3 would greatly improve current
understanding of the transcription factors and target genes that
mediate hair cell differentiation and maturation. Such an
understanding may also aid in the explanation of the mechanism
by which POU4F3 mutation causes hearing loss in humans.
To date, the only known direct targets of POU4F3 are BDNF,
NT-3 and Caprin-1 [14,15], though the expression of other genes
is strongly associated with POU4F3 expression [14,16,17]. In
previous work we identified Caprin-1 as a direct target of POU4F3
in a subtractive hybridization screen that was carried out in UB/
OC-2 cells – a conditionally immortal cell line, derived from the
developing mouse inner ear sensory epithelium, that displays
expression of hair cell markers [18]– that were manipulated to
differentially express POU4F3 [15]. The Caprin-1 59 flanking
sequence contains POU4F3 binding sites which mediate repres-
sion of Caprin-1 expression by POU4F3 [15]. We showed that
Caprin-1, which is known to promote stress granule formation
[19–21], is expressed in both the hair cells and supporting cells of
the organ of Corti as well as being involved in the hair cell
response to stress [15].
The same subtractive hybridization screen also returned the
orphan thyroid nuclear receptor Nr2f2 as a putative target of
PLOS ONE | www.plosone.org 1 November 2014 | Volume 9 | Issue 11 | e112247
POU4F3. Nr2f2 is an orphan steroid/thyroid hormone nuclear
receptor which is expressed in a range of organs in the developing
embryo [22] as well as adult tissues [23]. Its most essential roles in
development are in angiogenesis, heart development and remod-
elling the primitive capillary plexus into large and small
microcapillaries; as demonstrated by knocking out the Nr2f2
gene in mice. This change results in lethality at around E10 that is
likely to be due to haemorrhage and oedema in the brain and
heart [24]. Further study of the function of NR2F2 in the vascular
system has revealed its importance in designating venous identity
via its suppression of the Notch signalling pathway. In addition to
its previously reported roles in generation of venous identity, these
studies show a role for NR2F2 in cell fate determination [25].
Despite having a general role in embryogenesis, NR2F2 also
demonstrates more specific actions in organogenesis. In the brain,
it regulates cell migration [26]; it is essential for correct stomach
patterning [27]; and has been proposed to be involved in dorso-
ventral patterning of the mammalian retina [28]. Both NR2F2
and its closely related family member NR2F1 have been shown to
be variably expressed in the developing mouse inner ear. NR2F2 is
expressed in the distal tip of the elongating cochlear epithelium at
E10 to E13.5; homogeneous expression is seen across cell types of
both the greater and lesser epithelial ridges (GER & LER) in the
apical coil at E15.5; and predominantly LER expression is seen in
the apical-to-middle coil at the same age [29].
In contrast to NR2F2, NR2F1 expression in the developing
inner ear between E14.5 and E15.5 becomes more confined to the
GER in the apical cochlea. In the basal cochlea, its expression
extends to the LER and the level of expression appears to decrease
[29]. This decrease in basal expression correlates with the wave of
hair cell differentiation from base to apex [30]. Consistent with a
role in cochlear development, Nr2f12/2 mice display shortened
cochlear ducts with an increased number of hair cells in the mid-
to-apical cochlear turns; an anomaly which appears consistent
with a role in Notch regulation of organ of Corti differentiation
[31].
Though NR2F2 has been implicated in a number of
developmental processes, its expression is known to be maintained
in postnatal vertebrates. Post-natal NR2F2 expression is perhaps
best-characterised in the liver where it is known to downregulate
the apolipoprotein A1 (apoA1) gene [32]. However, its expression
is maintained in the adult mouse brain and in a wide array of
postnatal human tissue types, suggesting additional uncharac-
terised roles in cell maintenance [23,33].
In this paper, we present evidence for the direct regulation of
Nr2f2 by POU4F3. Furthermore, we show that NR2F2 expres-
sion is maintained postnatally in the mouse cochlear sensory
epithelium. These data add to our understanding of the
downstream effects of POU4F3 signalling and widen the array
of possible functions of NR2F2 to the postnatal inner ear.
Materials and Methods
Subtractive hybridization
POU4F3-regulated genes were identified as previously de-
scribed [15]. Briefly, two populations of UB/OC-2 cells [18] were
created. In one population, POU4F3 expression was increased by
stable transfection of a Pou4f3 expression construct. In the other,
POU4F3 expression was reduced by stable transfection of an
antisense Pou4f3 construct. cDNA was prepared from these two
cell populations and used in a subtractive hybridization screen
using the PCR-Select cDNA Subtraction kit (Clontech). Differen-
tially expressed cDNA sequences identified in this analysis were
verified by a series of hybridization experiments with cDNA from
the original analysis and virtual northern blot experiments with
cDNA from transiently transfected cells to increase the stringency
of the analysis [15]. Clones that displayed differential expression
were selected for further analysis.
BLAST analysis
Following identification of differentially expressed transcripts by
subtractive hybridization, cloned cDNA was subjected to Sanger
sequencing. This was followed by BLASTN analysis of transcript
sequences against the ENSEMBL mouse cDNA database (NCBI
m35) with a ‘near-exact match’ stringency. Matches were
confirmed by alignment of clone sequence to the cDNA sequence
in the ENSEMBL database using the BioEdit software package
[34].
Nr2f2 59 flanking region Genomatix analysis
The Genomatix Gene2Promoter software [35] was used to
identify predicted Nr2f2 promoters for analysis. The promoter
that corresponded to the transcript that best matched the Nr2f2
transcript identified in the BLAST analysis was selected for further
investigation (GXP_158616). To identify putative POU4F3
binding sites in this predicted promoter, the selected region was
interrogated using the Genomatix MatInspector [36,37] and
ModelInspector [38] programs. Binding sites for analysis were
selected on the basis of search stringency, proximity to the
predicted transcriptional start site and promoter architecture at the
relevant site. Two predicted binding sites were selected for
functional analysis and were named POU recognition element-1
(PRE1) and POU recognition element-2 (PRE2).
Electrophoretic mobility-shift assay (EMSA) analysis
Both in vitro translated protein and UB/OC-2 cell nuclear
protein extract were used. Pou4f3 was cloned into the pGEM-T
Easy vector (Promega) under the control of the T7 or SP6
promoter and in vitro translated protein was generated using
either the TNT-T7 Coupled Reticulocyte Lysate System (Pro-
mega) or the TNT-SP6 Quick Coupled Transcription/Translation
System (Promega).
Double-stranded probe oligonucleotides were labelled in a
standard T4 kinase reaction with c32P cATP (GE Healthcare)
using 50 ng probe per reaction. Assay reactions containing 10 ml
2x Parker buffer (16% Ficoll, 40 mM HEPES at pH 7.9, 100 mM
KCl, 2 mM EDTA at pH 8.0 and 1 mM DTT), 3 mg poly(dI?dC),
2–4 ml nuclear protein extract or in vitro translated protein and 0–
1000 ng non-radiolabelled competition probe were made up to a
total volume of 20 ml and incubated on ice for ten minutes. Assay
reactions were subsequently incubated at room temperature for
15–30 minutes following the addition of 1 ng labelled probe.
Reactions were loaded onto a 4% polyacrylamide (29:1), 0.25x
TBE gel and electrophoresed in 0.25x TBE at 200 V for one to
three hours at 4uC. The polyacrylamide gel was subsequently
dried and autoradiographs were produced by exposure of dried
gels to X-Ray film at 280uC or room temperature for varying
durations.
Luciferase assays
The 4.2 kb-Nr2f2-Luc Nr2f2 59 flanking region luciferase
reporter construct was kindly provided by Dr M Vasseur-Cognet
[39]. The PRE1-Luc and PRE2-Luc POU recognition element
reporter constructs were cloned in our laboratory by inserting a
single copy of PRE1 and PRE2 into the pGL4.23 [luc2/minP]
reporter construct (Promega). The Dreidel expression construct
was created by subcloning the Dreidel sequence from a pHM6
Regulation of Nr2f2 by the DFNA15 Deafness Gene Pou4f3
PLOS ONE | www.plosone.org 2 November 2014 | Volume 9 | Issue 11 | e112247
vector, kindly provided by Professor K Avraham [40], into pSi
(Promega).
For transient transfections, ND7 cells [41] were plated at
approximately 26105 cells/well density in six-well plates and
cultured at 37uC with 5% carbon dioxide in L-glutamine-
containing L-15 media supplemented with 10% heat-inactivated
foetal bovine serum, 0.32% sodium bicarbonate, 0.25% glucose
and 0.85% penicillin-streptomycin. The next morning, the culture
medium was changed to DMEM with 10% heat-inactivated foetal
bovine serum for at least one hour prior to transfection. Cells were
transfected using a standard calcium precipitation method [42]
with 100–200 ng reporter construct, 1–3 mg expression vector and
10 ng pRL-null vector (Promega). The total amount of DNA used
per transfection was kept constant using pSi (Promega). Cells were
then incubated for a minimum of six hours followed by washing
and returning to normal culture media. Cells were harvested at
least 24 hours later and assayed using the Dual-Luciferase kit
(Promega).
Site-directed mutagenesis
The 4.2 kb-Nr2f2-Luc-Mut reporter construct was generated
by overlap extension PCR [43] using the following mutagenic
primers (mutated bases underlined): PRE1 forward mutagenic
primer, CTTTTTAGCCGATTTGATCACTTTGATT; PRE1
reverse mutagenic primer, AATCAAAGTGATCAAATCGGC-
TAAAAAG; PRE1 forward flanking primer,
AAGCCTCCGGGTCGGGCCCGGAG; PRE1 reverse flanking
primer, TCCGCGCTCCGGGGTCCAC; PRE2 forward muta-
genic primer, GATAAAGTTGAGAGGAATTTATTT-
TAATTGCAGGGTAACAATGAGGTGAAGTCTGGTGTT;
PRE2 reverse mutagenic primer, AACACCAGACTTCACCT-
CATTGTTACCCTGCAATTAAAATAAATTCCTCT-
CAACTTTATC; PRE2 forward flanking primer, GCTTAAT-
GAATTCCCATCACTTGC; PRE2 reverse flanking primer,
GGAATTCTCACAATCAACTAGCGG. The purified mutated
fragment of PRE2 was cloned into 4.2 kb-Nr2f2-Luc, replacing
the wild type sequence. The purified mutated fragment of PRE1
was cloned into this plasmid to create a double-mutant 4.2 kb-
Nr2f2-Luc-Mut. Further subcloning was carried out to correct
presumed PCR errors though a c to t missense mutation remained
288 bp downstream from the intended PRE1 mutagenesis site.
The double-mutant probe was used in luciferase assays as
described above.
Transcription factor binding site evolutionary
conservation analysis
The ECR Browser [44] was used to navigate to the region of the
human genome (build ‘‘hg19’’) that corresponded to the mouse
sequence for PRE1 (CTTTTTAGCATATTTGATCACTTT-
GATT) or PRE2 (GGAATTTATTTTAATTGCATCATAA-
CAATGAGGTGA). The view obtained was expanded to include
approximately 70 bp of flanking sequence and adjusted to include
only mouse, rat and chimpanzee alignments. This view was
submitted to the Mulan software and the phylogenetic tree
obtained was not adjusted. The results of the Mulan analysis were
submitted to MultiTF using the ‘vertebrates’ and ‘optimised for
function’ settings against the TRANSFAC Professional Version
10.2 library to identify evolutionarily conserved POU domain
transcription factor binding sites. Positional weight matrices
(PWMs) for POU-domain transcription factors were included in
this analysis as POU family binding sites are clearly related [4]
despite there being subtle sequence-specific differences in the
recognition elements of different POU4 family members [45]:
OCT1_B, OCT1_Q5, OCT1_Q6, OCT4, OCT_C, OCT_Q6,
POU1F1_Q6, POU3F2 and POU6F1.
Cryosectioning and immunocytochemistry
Adult (i.e. .P21) C57BL/6J mice, adult Sprague Dawley rats
and P1 C57BL/6J mice were killed in accordance with Schedule I
of the UK Animals (Scientific Procedures) Act (1986). This study
was approved by the UCL Biological Services Ethical Review
Committee. Inner ears were isolated and the apical bone of the
cochlea was perforated to facilitate fixation in 4% paraformalde-
hyde solution in PBS for one to two hours at room temperature or
overnight at 4uC. Cryoprotection was carried out by incubation of
samples in 30% sucrose in PBS at 4uC overnight. Tissue was
mounted in 1% low gelling agarose (Sigma-Aldrich) in PBS which
had been heated to 140uC and allowed to cool to 37uC. Once set,
a block was cut, attached to a cryostat chuck with OCT compound
and rapidly frozen by immersion in liquid nitrogen prior to
cryosectioning at 220 to 225uC. Sections of 15 mm were cut
using a CM1850 cryostat (Leica).
Prior to immunolabelling, sections were permeabilised and
blocked for one hour at room temperature with blocking solution
(10% goat serum in PBS) containing 0.1–0.5% Triton-X. Slides
were then incubated in blocking solution with an antibody raised
against NR2F2 (a kind gift from Dr M Studer) 1:1000 at 4uC
overnight [26]. Following three five-minute PBS washes, 2 mg/ml
Alexa 488-conjugated anti-rabbit secondary antibody, 1 Unit/ml
Alexa 633-conjugated Phalloidin and 5 mM DAPI in PBS or
blocking solution was added for two hours at room temperature.
Following three further five-minute PBS washes, samples were
mounted in Fluoromount G and visualised using a Zeiss LSM 510
Meta microscope. Relative expression comparisons were made
between apical to basal cochlear turns within individual slides.
Results
Identification of Nr2f2 as a putative target of POU4F3
In order to identify target genes of POU4F3 that may be
involved in hair cell survival and maintenance, a subtractive
hybridization was carried out in UB/OC-2 cells followed by serial
virtual Northern analysis as described previously [15]. One
putative upregulatory target of POU4F3 identified by this screen
was Clone D8. This clone was sequenced and subjected to BLAST
analysis against the ENSEMBL mouse cDNA database (based on
NCBI m35 data) to identify known mouse cDNA sequences to
which it corresponded. Clone D8 matched the 39 region of the
related Nr2f1 and Nr2f2 cDNA sequences which are highly
homologous in this region. However, the match to Nr2f2
(ENSMUST00000032768) was more extensive (343 bp, 100%
sequence similarity: p = 8.66102273) than the match to Nr2f1
(116 bp, 87% sequence similarity: p = 3.3610225). Therefore, this
analysis identified Nr2f2 as an upregulated transcript from the
POU4F3 forward subtractive hybridization library.
As Nr2f2 was identified as a putative upregulatory target of
POU4F3 in the subtractive hybridization screen, its expression in
UB/OC-2 cells was investigated as these cells constitutively
express POU4F3 in their proliferating state and are derived from
the mouse inner ear at E13, i.e. after the onset of NR2F2
expression in the developing ear [18,29]. Nr2f2 mRNA and
protein were found to be present in proliferating UB/OC-2 cells
by reverse transcriptase PCR, western blot and immunohisto-
chemistry (Figure S1). NR2F2 expression was localised to UB/
OC-2 cell nuclei, consistent with its reported subcellular localisa-
tion [26,29].
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POU4F3 binds two sites in the Nr2f2 59 flanking region
identified by Genomatix software analysis
For POU4F3 to directly regulate a gene, it must bind to the
target gene promoter via a sequence specific binding site. To
establish whether Nr2f2 is a direct or indirect target of POU4F3
we performed bioinformatic and functional analysis of the Nr2f2
59 flanking region to identify any such binding sites. The
Genomatix MatInspector and ModelInspector programmes were
used to interrogate the most proximal 5 kb of the predicted Nr2f2
promoter (GXP_158616, identified by the Gene2Promoter
software) [35–38].
Using MatInspector software at the highest stringency (0.05) a
number of putative POU4F3 binding sites were identified. Of
these, the two most proximal to the Nr2f2 transcriptional start site
were selected for further analysis and designated POU regulation
element (PRE) 1 and 2 (Figure 1a). PRE2 also overlapped with a
SORY OCT1 module identified using the Genomatix ModelIn-
spector software i.e. PRE2 is within an experimentally verified
functional promoter subunit that contains predicted binding sites
for both OCT1 and SORY.
The ability of POU4F3 to bind these putative recognition
elements was tested by electrophoretic mobility-shift assay (EMSA)
analysis. In vitro translated POU4F3 produced bandshifts for both
PRE1 and PRE2 that were not reproduced by in vitro translated
luciferase protein (Figure 1b), demonstrating POU4F3-specific
binding to PRE1 and PRE2. In addition, endogenous UB/OC-2
cell POU4F3 was shown to bind to these two sequences in EMSA
competition analysis (Figure 1c). Hence, UB/OC-2 cell nuclear
protein extract binding was reduced with increasing amounts of
unlabelled POU4F3 consensus sequence but not with an excess of
an unrelated transcription factor binding site, demonstrating the
presence of POU4F3 in the shifted complex (Figure 1c).
POU4F3 activates the 4.2 kb Nr2f2 59 flanking region
containing PRE1 and PRE2
Having demonstrated the ability of POU4F3 to bind to PRE1
and PRE2, we tested whether POU4F3 can regulate the Nr2f2 59
flanking region that contains these sites. A luciferase reporter
construct containing 4.2 kb of the Nr2f2 59 flanking region
(4.2 kb-Nr2f2-Luc, Figure 2a) was used in co-transfection studies
in ND7 cells. This analysis demonstrated a dose-dependent
increase in 4.2 kb-Nr2f2-Luc activity in response to increasing
POU4F3 levels. Compared to basal activity, promoter activity was
five times higher at the maximal amount of POU4F3 expression
construct used (3 mg) and was not replicated with a non-DNA-
binding POU4F3 mutant (dreidel), showing that this activation is
dependent on POU4F3-specific DNA binding (Figure 2b).
These experiments were also conducted in UB/OC-2 cells but
gave inconsistent results (data not shown). Experiments in this cell
type may have been complicated by a number of factors. For
example, proliferating UB/OC-2 cells endogenously express
POU4F3 which may have been sufficiently expressed to mask
the variation induced by the co-transfected POU4F3 expression
construct. UB/OC-2 cells also vary their POU4F3 expression
depending on differentiation status; it is, therefore, possible that
POU4F3 expression varies more dynamically than is currently
known. Given these possibilities, ND7 cells were used as POU4F3
activation of Nr2f2 constructs was consistent in this assay.
To investigate whether POU4F3 activates 4.2 kb-Nr2f2-Luc
via PRE1, PRE2 or a combination of both, each was cloned
upstream of a minimal promoter in a luciferase vector to generate
PRE1-Luc and PRE2-Luc (Figure 2a) and used in co-transfection
studies with increasing amounts of POU4F3. In ND7 cells, co-
transfection with a POU4F3 expression construct produced a 1.8-
fold upregulation of PRE1-Luc (Figure 2c) and a 1.5-fold
upregulation of PRE2-Luc (Figure 2d). In both cases, this
activation required functional POU4F3 as dreidel mutant protein
did not upregulate either binding site (Figure 2c & d).
Activation of 4.2 kb-Nr2f2-Luc is dependent on PRE1 and
PRE2
To confirm that POU4F3-mediated regulation of the Nr2f2
promoter is dependent on PRE1 and PRE2, both sites were
mutated to attenuate POU4F3 binding. Mutant versions of PRE1
and PRE2 were synthesised and tested in EMSA analysis which
showed effective attenuation of in vitro translated POU4F3
binding (Figure 3a). Both mutations were then introduced into
the 4.2 kb-Nr2f2-Luc construct by overlap extension PCR to
produce 4.2 kb-Nr2f2-Luc-Mut and the effect of these mutations
on POU4F3-specific activation was investigated in co-transfection
studies. Regulation of 4.2 kb-Nr2f2-Luc-Mut was attenuated to
1.3-fold compared to a two-fold activation of 4.2 kb-Nr2f2-Luc at
the maximal amount of POU4F3 expression construct used (1 mg).
This suggests that PRE1 and PRE2 are required for activation of
the Nr2f2 59 flanking region by POU4F3 (Figure 3b).
Evolutionary Conservation of PRE1 and PRE2
Similar to protein-coding regions of the genome, functionally
important regulatory elements are conserved across species [46–
48]. Therefore, the evolutionary conservation of the POU4F3
binding sites PRE1 and PRE2 within the Nr2f2 59 flanking
sequence was investigated to indicate the potential functional
importance of these sites in vivo. The Mulan program performs
an analysis of sequences from multiple species; constructs
phylogenetic trees; creates alignments; and identifies evolutionarily
conserved regions. The output of this analysis is used as input for
the MultiTF program which identifies evolutionarily conserved
transcription factor binding sites [48].
The MultiTF program relies on the TRANSFAC Professional
Version 10.2 library [49], however, no PWM is available for
POU4F3 in this database. Therefore, PWMs for closely related
transcription factor binding site families (i.e. OCT and POU) were
used as POU family binding sites are closely related [4]. This
analysis revealed two evolutionarily conserved binding sites in the
human region of NR2F2 that correspond to the PRE1 locus in the
mouse Nr2f2 59 flanking region. The overlapping binding sites
identified correspond to OCT1 and OCT_C PWMs (Figure 4a).
No such evolutionarily conserved binding sites were identified for
PRE2 which is less well-conserved than PRE1 across the species
assessed (Figure 4b). This conservation suggests that PRE1 is more
likely to play an important role in the regulation of Nr2f2
expression in vivo over recent evolution.
Expression of NR2F2 in the embryonic rat inner ear
The inner ear’s function is primarily achieved by mechanosen-
sory hair cells which are surrounded by support cells and
extracellular matrix that form a complicated microanatomy which
is required to achieve the special senses of hearing and balance.
Accordingly, the development of this organ requires a complex co-
ordination of cellular proliferation, differentiation and morphoge-
netic movement [50].
POU4F3 and NR2F2 are both expressed in the embryonic
mouse inner ear. In the developing cochlea, Pou4f3 expression
begins in the base and extends to include all hair cells of the inner
ear by birth. This expression is unique to hair cells and correlates
with the wave of hair cell differentiation [6–8,51]. NR2F2 is more
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widely expressed in the developing apical organ of Corti with its
expression level gradually reducing to become more refined to the
LER in the basal cochlea [29].
The putative interaction of POU4F3 and Nr2f2 in the inner ear
was investigated by further characterising the expression profile of
NR2F2 in the E18 rat inner ear. NR2F2 expression was seen
throughout the developing cochlea at this age with strongest
expression seen in the greater epithelial ridge, lesser epithelial
ridge and supero-medial wall of the apical cochlear duct
(Figure 5). Expression decreased in an apical-to-basal direction
with NR2F2 expression being limited to the lesser epithelial ridge
of the basal cochlear duct (Figure 5). This embryonic expression
Figure 1. Identification and verification of POU4F3 recognition elements in the Nr2f2 59 flanking region. a. Schematic diagram of the
location of two putative POU4F3 recognition elements (PREs) identified in the Nr2f2 59 flanking region and used in EMSA analysis. Underlined bases
correspond to POU4F3 binding sites predicted by MatInspector software with capital letters denoting matches to the core sequence. The asterisks
signify matrix position conservation .60/100 (TSS, transcriptional start site and UTR, un-translated region). b. Sequences shown in a were used as
radiolabelled probes in EMSA analysis with in vitro translated POU4F3 or a Luciferase control. Bandshifts due to protein-specific binding by POU4F3
are indicated by arrowheads. c. The same probes were used in EMSA analysis with UB/OC-2 cell nuclear protein extract. Reactions were incubated
either alone, with UB/OC-2 cell nuclear protein extract or with the nuclear protein extract and an excess of non-radiolabelled competitor
oligonucleotide as indicated. The ‘P’ suffix refers to non-radiolabelled POU4F3 binding sequence whereas the ‘A’ suffix indicates a non-radiolabelled
AP4 binding sequence. POU4F3-sequence-specific shifts are indicated by arrowheads.
doi:10.1371/journal.pone.0112247.g001
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profile is in keeping with the previously reported expression profile
of NR2F2 in the embryonic mouse inner ear [29].
NR2F2 expression in the postnatal mouse inner ear
The subtractive hybridization experiment that identified Nr2f2
as a putative target of POU4F3 was conducted to elucidate the
pathway through which POU4F3 affects hair cell differentiation
and survival. In the murine model, hair cell differentiation requires
POU4F3 in the embryonic and early postnatal period [8].
However POU4F3 is also required for hair cell survival and is
expressed postnatally [10–12,17]. It must therefore influence its
targets postnatally – though the targets required for hair cell
maturation will not necessarily be identical to those required for
maintenance. As NR2F2 is expressed postnatally in a number of
organs, we investigated whether it is expressed in the postnatal
inner ear to ascertain whether it is has the potential to play a role
in hair cell maintenance as a POU4F3 target.
As in the embryonic cochlea, NR2F2 expression was wide-
spread in the postnatal mouse cochlea both within and around the
sensory epithelium. Throughout the P1 cochlea a typical nuclear
pattern of NR2F2 expression was seen in hair cells as well as a
number of supporting cells of the sensory epithelium i.e. Hensen
cells, Claudius cells and inner sulcus cells (Figure 6). Expression
appeared stronger in the apical coil including the hair cells as
compared to the basal coil and hair cells. This apical-to-basal
expression gradient was maintained in the adult cochlea where
NR2F2 expression in the basal cochlea further decreased so that
NR2F2 expression was no longer observed in the nuclei of basal
hair cells. As in the cochlea, NR2F2 expression is widespread
though variable in the postnatal cristae where its expression is
greatest within the sensory epithelium, including hair cells
(Figure 6).
Discussion
POU4F3 expression is essential for hair cell differentiation and
maintenance [6–8,10–12]. However, it’s only known direct targets
(BDNF, NT-3 and Caprin-1) and downstream targets (Gfi1 and
Lhx3) do not sufficiently explain the link between POU4F3 and
Figure 2. POU4F3-mediated activation of PRE1, PRE2 and a 4.2 kb Nr2f2 59 flanking sequence. a. Schematic diagram of reporter
constructs used in luciferase reporter assays in ND7 cells. POU4F3 recognition element (PRE) 1 and 2 are shown in an Nr2f2 59 flanking region
fragment (grey box) cloned upstream of a luciferase reporter gene (LUC). The location of this fragment relative to the Nr2f2 transcriptional start site is
shown. b. Evaluation of the response of 4.2 kb-Nr2f2-Luc to increasing levels of POU4F3 or dreidel mutant POU4F3 (Ddl) expression construct. The
luciferase activity of the reporter is normalised to its response to the empty expression vector and results are expressed relative to this. c. Response of
the PRE1-Luc reporter construct in co-transfection experiments with POU4F3 and dreidel expression constructs. d. Evaluation of the response of PRE2-
Luc in similar experiments to c. Error bars represent the s.e.m in b, c and d (n = 6 for each data point).
doi:10.1371/journal.pone.0112247.g002
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the hair cell phenotype [14–16,40]. In this paper, we furthered the
understanding of this pathway by identifying and verifying Nr2f2
as a new regulatory target of POU4F3.
A combination of bioinformatic analysis, EMSA and reporter
gene assays demonstrated that POU4F3 binds to two sites in the
4.2 kb Nr2f2 59 flanking region and that the most proximal
binding site (PRE1) is well-conserved through recent evolution.
The sites identified were shown to be required for POU4F3-
mediated upregulation of this region as their mutation attenuates
this effect and were sufficient to confer POU4F3 activation upon a
heterologous promoter (Figure 2). These results suggest that Nr2f2
is a direct regulatory target of POU4F3.
NR2F2 in the developing inner ear
Experiments in embryonic rats confirmed expression of NR2F2
in the developing cochlea (Figure 5) [29]. The widespread
expression of NR2F2 indicates the presence of otic regulators of
this gene. However, our data reveal that hair cell-selective Nr2f2
expression could be regulated by POU4F3 given its hair cell-
specific expression pattern in the inner ear [6,8].
As well as the POU4F3 binding sites described here, the Nr2f2
59 flanking region is known to contain response elements for
retinoic acid, sonic hedgehog, and Notch [52–54] which are all
involved in inner ear development [50,55,56]. Furthermore,
NR2F2 is known to mediate signalling between mesenchymal
and endothelial compartments and it is thought that organs which
require the differentiation of mesenchyme to epithelium display
NR2F2 expression in the mesenchyme [57]. Epithelial-mesenchy-
mal interactions give rise to most of the otic capsule and retinoic
acid (which interacts with NR2F2) is thought to orchestrate
mesenchyme-epithelial interactions in inner ear morphogenesis
[54,57,58]. Though their relevance in the inner ear is not yet
known, NR2F2 could act as an integrator of these important
developmental pathways.
NR2F2 in the postnatal inner ear
The potential role of NR2F2 in hair cell survival and
maintenance was investigated in the adult inner ear. In the
postnatal mouse cochlea, NR2F2 expression is highest in the apex
and falls to undetectable levels in basal hair cells. This pattern
correlates with a previous report of higher apical POU4F3
expression in the postnatal rat cochlea [17]. The potentially
matching expression pattern of these two transcription factors, if
verified, supports the possibility that their interaction is active in
the postnatal cochlea.
Apical hair cells are responsible for the detection of low
frequency sounds and are the first hair cells of the cochlea to exit
the cell cycle at approximately E13 in the developing mouse [59].
However, these hair cells are the last to complete their
differentiation as the wave of hair cell differentiation proceeds
from base to apex [30]. Though the gradient of NR2F2 expression
seen in development mirrors hair cell differentiation this pattern
persists despite full differentiation, i.e. after the onset of hearing.
The nuclear expression pattern in these cells suggests that NR2F2
is acting as a transcription factor. However, as the postnatal role of
NR2F2 is currently poorly understood, further work is required to
determine its role in the hair cells of the inner ear.
The postnatal cochlear expression pattern of NR2F2 reported
here is contrary to previously published data where it was not
detected in the postnatal mouse organ of Corti [29]. This may be
explained by several factors. For example, different antibodies
were used in these experiments and tissue was obtained from
different mouse strains [26,29,60]. As transcription factors
typically have low expression levels, a small change in the
sensitivity of the differing immunohistochemistry assays could
account for this discrepancy.
In addition to its cochlear expression, NR2F2 expression was
detected in the nuclei of hair cells and supporting cells of the
postnatal mouse crista. The cristae form part of the vestibular
apparatus and are required for the detection of rotational
acceleration. A role for NR2F2 in this system would, therefore,
imply a role in balance function. This is the first report of NR2F2
Figure 3. POU4F3 recognition element mutation attenuates
POU4F3 binding and activation of the Nr2f2 59 flanking region.
a. EMSA analysis of POU4F3 recognition element mutations on POU4F3
binding. Probes were either incubated alone or with in vitro translated
POU4F3. Closed arrowheads indicate POU4F3-specific PRE1 bandshifts
and the open arrowhead indicates the POU4F3-specific PRE2 bandshift.
The mutation of each site severely compromises the ability of POU4F3
to bind to each sequence. b. Luciferase reporter assay upon co-
transfection of POU4F3 with the 4.2 kb-Nr2f2-Luc-Mut reporter
construct. Error bars represent the s.e.m (n = 6 for each data point).
doi:10.1371/journal.pone.0112247.g003
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expression in the vestibular system and further work to improve
the understanding of its relative expression and function at this
site, as compared to the cochlea, may assist in elucidation of the
molecular basis for phenotypic differences between cochlear and
vestibular hair cells.
NR2F2 function in the inner ear
Given the diversity of genes and pathways in which NR2F2 is
involved, it is possible that NR2F2 could play a novel role in
cochlear development and maintenance. However, despite
knowledge of its regulation, the function of NR2F2 in the inner
ear remains unknown. Furthermore, the complex regulation of
Nr2f2 and its various targets [61] make it difficult to differentiate
any effects of POU4F3 from other activators of Nr2f2 which are
known to be important in inner ear differentiation e.g. sonic
hedgehog [62]. The hair-cell-specific expression of POU4F3
suggests that its interaction with Nr2f2 represents a regulatory
mechanism that may be restricted to these sensory cells.
It is notable that a number of other reported regulatory targets
of POU4F3 are transcription factors, including Lhx3 and Gfi-1
[16,40] suggesting that it lies at the head of a complex and diverse
regulatory pathway and may act as master-regulator of hair cell
function. This is certainly consistent with the evidence provided
from both transgenic mice with targeted deletion of Pou4f3 and
humans with POU4F3 mutations, which exhibit loss of hearing
due to loss of hair cell function.
Postnatally, mitochondrial biogenesis has been implicated in
hair cell survival following the administration of ototoxic
medications and noise exposure [63,64]. NR2F2 has been shown
to be involved in white adipose tissue mitochondrial biogenesis
and may therefore influence this otoprotective function in
postnatal hair cells [65]. Also, established roles of NR2F2 such
as angiogenesis may be relevant to other cochlear cells that do not
express POUF43 but do express NR2F2 [65].
Embryonic lethality at E10 makes it hard to assess the effect of
Nr2f2 knockout on the developing mouse inner ear and no
relevant conditional knockout mouse exists [24]. In the adult
Figure 4. Evolutionary conservation of transcription factor binding sites in the Nr2f2 59 flanking region. Schematic representation of the
conservation of the region surrounding the human PRE1 sequence (a) and the human PRE2 sequence (b) compared to corresponding mouse, rat and
chimpanzee sequences. a. The well-conserved PRE1 sequence is indicated by asterisks with evolutionarily conserved binding sites for the POU
domain transcription factors OCT1 and OCT_C indicated by horizontal bars. Conserved bases are represented by black boxes with mismatches in
grey. b. PRE2 is less well conserved with eight mismatched bases and no corresponding POU domain transcription factor binding sites in the
TRANSFAC database. Conserved bases are again represented by black boxes with mismatches in grey.
doi:10.1371/journal.pone.0112247.g004
Figure 5. Expression of NR2F2 in the embryonic rat cochlea. a. Overview of NR2F2 expression throughout the cochlea at E18. NR2F2 is most
strongly expressed in the cochlear duct. In the apical duct, strong expression is seen in the super-medial wall (S-MW), greater epithelial ridge (GER),
and lesser epithelial ridge (LER). This expression is reduced to the lesser epithelial ridge in the basal duct (arrowhead). b–e. Apical cochlear duct; f–i.
Middle cochlear duct; and j–m. Basal cochlear duct. b, f & j, cell nuclei stained with DAPI; c, g & k, NR2F2 labelling; d, h & l, filamentous actin labelled by
Phalloidin; and e, i & m, Merge of DAPI (blue), NR2F2 (green) and Phalloidin (red), scale bars: 100 mm in a and 20 mm in e, i & m.
doi:10.1371/journal.pone.0112247.g005
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Nr2f2 knockout mouse, there is no overt phenotype, though
hearing has yet to be assessed in these animals [66]. However,
postnatal expression of NR2F2 in a number of organs – including
the inner ear – suggests that it plays a functional role beyond
Figure 6. Expression of NR2F2 in the postnatal mouse inner ear. Cryotome sections of P1 and adult mouse inner ears were subjected to
immunohistochemistry in order to characterise their postnatal NR2F2 expression pattern. NR2F2 labelling is seen throughout the sensory epithelia of
the cochlea and cristae. In the cochlea, NR2F2 labelling is of greater intensity in the apex than the base. NR2F2 is expressed in the nuclei of apical hair
cells at all ages examined. In P1 mice, NR2F2 expression is reduced in basal hair cells. In adult mice, the expression of NR2F2 in basal hair cell nuclei
appears further reduced. NR2F2 is also expressed in the hair cells of the cristae of the semicircular canals and this expression is maintained into
adulthood. In merged images DAPI is blue, NR2F2 is green, Phalloidin is red, arrowheads indicate hair cells and scale bars: 20 mm.
doi:10.1371/journal.pone.0112247.g006
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development. Current evidence suggests that NR2F2 is most
important in regeneration and de-differentiation in pathological
conditions [65].
Therefore, beyond the verification of POU4F3 regulation of
Nr2f2 in vivo, the characterisation of NR2F2 function in
development and under pathological conditions in mature animals
is essential to clarify the putative role of this versatile orphan
nuclear receptor in the development and maintenance of hearing
and balance.
Supporting Information
Figure S1 Nr2f2 expression in UB/OC-2 cells. Nr2f2
expression was investigated in proliferating UB/OC-2 cells. a,
cDNA was generated from proliferating UB/OC-2 cells and
subjected to PCR which demonstrated amplification of the
predicted Nr2f2 fragment (213 bp). Integrity of the cDNA was
demonstrated by amplification of Gapdh (450 bp) with sizes of
amplified fragments measured against a 1 kb marker (M).
Adjacent lanes have been removed for presentation purposes. b,
The specificity of an anti-NR2F2 antibody was verified by western
blot. A predominant 50 kDa band (arrow) with the expected
molecular weight of NR2F2 is detected. Immunohistochemistry
was carried out with (c) and without (d, secondary antibody alone)
an anti-NR2F2 antibody in UB/OC-2 cells. This analysis showed
NR2F2 expression localised to OC-2 cell nuclei. i, nuclei were
stained DAPI; ii, NR2F2 expression; iii, Phalloidin labelling; and
iv, shows a merged image of i, ii and iii with DAPI in blue, NR2F2
in green and Phalloidin in red. Scale bars: 100 mm.
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